184 related articles for article (PubMed ID: 16793067)
1. Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test.
Sevostianova N; Danysz W
Neuropharmacology; 2006 Sep; 51(3):623-30. PubMed ID: 16793067
[TBL] [Abstract][Full Text] [Related]
2. Effect of metabotropic glutamate 5 receptor antagonists on morphine efficacy and tolerance in rats with neuropathic pain.
Zhou Q; Wang J; Zhang X; Zeng L; Wang L; Jiang W
Eur J Pharmacol; 2013 Oct; 718(1-3):17-23. PubMed ID: 24041921
[TBL] [Abstract][Full Text] [Related]
3. mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy.
Löscher W; Dekundy A; Nagel J; Danysz W; Parsons CG; Potschka H
Neuropharmacology; 2006 Jun; 50(8):1006-15. PubMed ID: 16563443
[TBL] [Abstract][Full Text] [Related]
4. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities.
Zhu CZ; Wilson SG; Mikusa JP; Wismer CT; Gauvin DM; Lynch JJ; Wade CL; Decker MW; Honore P
Eur J Pharmacol; 2004 Dec; 506(2):107-18. PubMed ID: 15588730
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.
Pietraszek M; Sukhanov I; Maciejak P; Szyndler J; Gravius A; Wisłowska A; Płaźnik A; Bespalov AY; Danysz W
Eur J Pharmacol; 2005 May; 514(1):25-34. PubMed ID: 15878321
[TBL] [Abstract][Full Text] [Related]
6. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
Kotlinska J; Bochenski M
Eur J Pharmacol; 2008 Nov; 598(1-3):57-63. PubMed ID: 18838071
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivo.
Szydlowska K; Kaminska B; Baude A; Parsons CG; Danysz W
Eur J Pharmacol; 2007 Jan; 554(1):18-29. PubMed ID: 17109843
[TBL] [Abstract][Full Text] [Related]
8. The role of group I mGlu receptors in the expression of ethanol-induced conditioned place preference and ethanol withdrawal seizures in rats.
Kotlinska JH; Bochenski M; Danysz W
Eur J Pharmacol; 2011 Nov; 670(1):154-61. PubMed ID: 21946112
[TBL] [Abstract][Full Text] [Related]
9. Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learning.
Gravius A; Pietraszek M; Schäfer D; Schmidt WJ; Danysz W
Behav Pharmacol; 2005 Mar; 16(2):113-21. PubMed ID: 15767847
[TBL] [Abstract][Full Text] [Related]
10. Effect of selective antagonists of group I metabotropic glutamate receptors on the micturition reflex in rats.
Guarneri L; Poggesi E; Angelico P; Farina P; Leonardi A; Clarke DE; Testa R
BJU Int; 2008 Sep; 102(7):890-8. PubMed ID: 18489527
[TBL] [Abstract][Full Text] [Related]
11. The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats.
Rasmussen K; Martin H; Berger JE; Seager MA
Neuropharmacology; 2005 Feb; 48(2):173-80. PubMed ID: 15695156
[TBL] [Abstract][Full Text] [Related]
12. Effects of mGlu1 and mGlu5 metabotropic glutamate antagonists to reverse morphine tolerance in mice.
Smith FL; Smith PA; Dewey WL; Javed RR
Eur J Pharmacol; 2004 May; 492(2-3):137-42. PubMed ID: 15178357
[TBL] [Abstract][Full Text] [Related]
13. mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia.
Walker K; Reeve A; Bowes M; Winter J; Wotherspoon G; Davis A; Schmid P; Gasparini F; Kuhn R; Urban L
Neuropharmacology; 2001; 40(1):10-9. PubMed ID: 11077066
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
Kozela E; Pilc A; Popik P
Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
[TBL] [Abstract][Full Text] [Related]
15. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.
Busse CS; Brodkin J; Tattersall D; Anderson JJ; Warren N; Tehrani L; Bristow LJ; Varney MA; Cosford ND
Neuropsychopharmacology; 2004 Nov; 29(11):1971-9. PubMed ID: 15305166
[TBL] [Abstract][Full Text] [Related]
16. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
Liechti ME; Markou A
Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
[TBL] [Abstract][Full Text] [Related]
17. The role of metabotropic glutamate receptor mGlu5 in control of micturition and bladder nociception.
Hu Y; Dong L; Sun B; Guillon MA; Burbach LR; Nunn PA; Liu X; Vilenski O; Ford AP; Zhong Y; Rong W
Neurosci Lett; 2009 Jan; 450(1):12-7. PubMed ID: 19027050
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of Group I metabotropic glutamate receptors antagonists on the expression of NMDA receptor NR1 subunit in morphine tolerant rats.
Liu JB; Yao YX; Jiang W
Neurosci Lett; 2009 Mar; 452(3):268-72. PubMed ID: 19348736
[TBL] [Abstract][Full Text] [Related]
19. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.
Anderson JJ; Rao SP; Rowe B; Giracello DR; Holtz G; Chapman DF; Tehrani L; Bradbury MJ; Cosford ND; Varney MA
J Pharmacol Exp Ther; 2002 Dec; 303(3):1044-51. PubMed ID: 12438526
[TBL] [Abstract][Full Text] [Related]
20. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands.
Gawel K; Jenda-Wojtanowska M; Gibula-Bruzda E; Kedzierska E; Filarowska J; Marszalek-Grabska M; Wojtanowski KK; Komsta L; Talarek S; Kotlinska JH
Physiol Behav; 2018 Mar; 185():112-120. PubMed ID: 29294304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
